| Sign In to gain access to subscriptions and/or personal tools. |
Intra-Arterial Transplantation of Adult Bone Marrow Cells Restores Blood Flow and Regenerates Skeletal Muscle in Ischemic LimbsWafic Said Stem Cell and Gene Therapy Research Laboratory, Texas Heart Institute at St Luke's Episcopal Hospital, Houston, Texas
Wafic Said Stem Cell and Gene Therapy Research Laboratory, Texas Heart Institute at St Luke's Episcopal Hospital, Houston, Texas
Department of Medicine (Cardiology), The University of Texas Health Science Center at Houston, Houston, Texas
Department of Medicine (Cardiology), The University of Texas Health Science Center at Houston, Houston, Texas
Wafic Said Stem Cell and Gene Therapy Research Laboratory, Texas Heart Institute at St Luke's Episcopal Hospital, Houston, Texas
Wafic Said Stem Cell and Gene Therapy Research Laboratory, Texas Heart Institute at St Luke's Episcopal Hospital, Houston, Texas, Department of Medicine (Cardiology), The University of Texas Health Science Center at Houston, Houston, Texas, pzoldhelyi{at}gmail.com
Objective: Bone marrow cell therapy promotes angiogenesis, but the cellular fate of bone marrow cells (BMCs) in the absence of immunosuppressant interventions is unclear. We created a model of severe hind limb ischemia to address whether BMCs form new blood vessels or differentiate into other tissues. Methods and Results: After ligating the common femoral artery in ApoE knockout mice, we injected either phosphate buffered saline (PBS) or 5 x 107 adult unfractionated BMCs obtained from green fluorescent protein-positive mice. Laser Doppler imaging of the ischemic limbs revealed that intra-arterial BMCs significantly increased blood flow recovery in ischemic limbs beginning 21 days after surgery and peaking at 27 days (61.8% ± 15% vs. 41.9% ± 13.9%, respectively, for BMCs and PBS, P < .05). The BMCs differentiated into small blood vessels, skeletal myofibers, and supporting membranes, and these changes were associated with increased serum levels of vascular endothelial growth factor (VEGF), fibroblast growth factor 2 (FGF-2), transforming growth factor β (TGFβ), interleukin 4 (IL-4), and tumor necrosis factor
Key Words: arteriosclerosis angiogenesis ApoE knockout mice peripheral arterial disease bone marrow cells
This version was published on October
1, 2009 Vascular and Endovascular Surgery, Vol. 43, No. 5,
433-443 (2009) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(TNF-